Fine tuning the immune response with PI3K

Immunological Reviews

Volumn 228, Issue 1, 2009, Pages 253-272

  Fruman, David A ^a   Bismuth, Georges ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CNRS   (France)

Author keywords

Cell differentiation; Cell proliferation; Cell trafficking; Lipid mediators; Signal transduction

Indexed keywords

CHEMOKINE; INOSITOL; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; MULTIPROTEIN COMPLEX; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; COMPREHENSION; HOMEOSTASIS; IMMUNE RESPONSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYNAPSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AUTOIMMUNE DISEASES; HUMANS; T-LYMPHOCYTES;

EID: 61849126233     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00750.x     Document Type: Article

References (178)

1. Vanhaesebroeck B, et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001 70 : 535 602.
2. Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004 22 : 563 598.
3. Huang CH, et al. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 2007 318 : 1744 1748.
4. Miled N, et al. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 2007 317 : 239 242.
5. Deane JA, et al. T cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 2007 109 : 2894 2902.
6. Fruman DA, et al. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 2000 26 : 379 382.
7. Fruman DA, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999 283 : 393 397.
8. Kharas MG, et al. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells. J Clin Invest 2008 118 : 3038 3050.
9. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998 18 : 1379 1387.
10. Suire S, et al. Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nat Cell Biol 2006 8 : 1303 1309.
11. Ciraolo E, et al. Phosphoinositide 3-kinase p110 beta activity: key role in metabolism and mammary gland cancer but not development. Science signaling 2008 1 : ra3.
12. Guillermet-Guibert J, et al. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA 2008 105 : 8292 8297.
13. Jia S, et al. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008 454 : 776 779.
14. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr., Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 1996 15 : 5256 5267.
15. Knight ZA, et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 2006 125 : 733 747.
16. Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 2008 1784 : 159 185.
17. Fruman DA, Satterthwaite AB, Witte ON. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 2000 13 : 1 3.
18. Bunnell SC, et al. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J Cell Biol 2002 158 : 1263 1275.
19. Bunnell SC, et al. Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol Cell Biol 2006 26 : 7155 7166.
20. Depoil D, et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 2008 9 : 63 72.
21. Weber M, et al. Phospholipase C-gamma2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen. J Exp Med 2008 205 : 853 868.
22. Donahue AC, Fruman DA. PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin Cell Dev Biol 2004 15 : 183 197.
23. Dustin ML. A dynamic view of the immunological synapse. Semin Immunol 2005 17 : 400 410.
24. Harwood NE, Batista FD. New insights into the early molecular events underlying B cell activation. Immunity 2008 28 : 609 619.
25. Krummel MF, Macara I. Maintenance and modulation of T cell polarity. Nat Immunol 2006 7 : 1143 1149.
26. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 2005 23 : 549 600.
27. Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y. T-cell receptor signaling to integrins. Immunol Rev 2007 218 : 65 81.
28. Dustin ML. Regulation of T cell migration through formation of immunological synapses: the stop signal hypothesis. Adv Exp Med Biol 2002 512 : 191 201.
29. Huang NN, Han SB, Hwang IY, Kehrl JH. B cells productively engage soluble antigen-pulsed dendritic cells: visualization of live-cell dynamics of B cell-dendritic cell interactions. J Immunol 2005 175 : 7125 7134.
30. Clayton E, et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 2002 196 : 753 763.
31. Hess KL, Donahue AC, Ng KL, Moore TI, Oak J, Fruman DA. Frontline: the p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Eur J Immunol 2004 34 : 2968 2976.
32. Jou ST, et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 2002 22 : 8580 8591.
33. Okkenhaug K, et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002 297 : 1031 1034.
34. Bilancio A, et al. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 2006 107 : 642 650.
35. Aman MJ, Lamkin TD, Okada H, Kurosaki T, Ravichandran KS. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 1998 273 : 33922 33928.
36. Scharenberg AM, et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998 17 : 1961 1972.
37. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001 19 : 275 290.
38. Lyubchenko T, dal Porto J, Cambier JC, Holers VM. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway. J Immunol 2005 174 : 3264 3272.
39. Vigorito E, Bardi G, Glassford J, Lam EW, Clayton E, Turner M. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J Immunol 2004 173 : 3209 3214.
40. Wang Y, Brooks SR, Li X, Anzelon AN, Rickert RC, Carter RH. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002 17 : 501 514.
41. Suzuki H, et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat Immunol 2003 4 : 280 286.
42. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med 1996 184 : 31 40.
43. Tomlinson MG, et al. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells. BMC Immunol 2001 2 : 4.
44. Saito K, et al. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 2003 19 : 669 678.
45. Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol 2003 4 : 780 786.
46. Arana E, et al. Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity 2008 28 : 88 99.
47. Fleire SJ, Goldman JP, Carrasco YR, Weber M, Bray D, Batista FD. B cell ligand discrimination through a spreading and contraction response. Science 2006 312 : 738 741.
48. Lin KB, et al. The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands. Immunity 2008 28 : 75 87.
49. Welch HC, et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002 108 : 809 821.
50. Reynolds LF, et al. Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways. J Exp Med 2002 195 : 1103 1114.
51. Walmsley MJ, et al. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 2003 302 : 459 462.
52. Minskoff SA, Matter K, Mellman I. Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens. J Immunol 1998 161 : 2079 2083.
53. Phee H, Rodgers W, Coggeshall KM. Visualization of negative signaling in B cells by quantitative confocal microscopy. Mol Cell Biol 2001 21 : 8615 8625.
54. Wagle NM, Faassen AE, Kim JH, Pierce SK. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1. J Immunol 1999 162 : 2732 2740.
55. Brauweiler A, et al. Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5′ inositol phosphatase (SHIP). J Exp Med 2000 191 : 1545 1554.
56. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 2003 4 : 287 294.
57. Omori SA, et al. Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 2006 25 : 545 557.
58. Suzuki A, et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 2003 197 : 657 667.
59. Donahue AC, Fruman DA. Proliferation and survival of activated b cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol 2003 170 : 5851 5860.
60. Matheu MP, Deane JA, Parker I, Fruman DA, Cahalan MD. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node. J Immunol 2007 179 : 2261 2269.
61. Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 2007 27 : 160 171.
62. Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007 8 : 992 1000.
63. Al-Alwan MM, Okkenhaug K, Vanhaesebroeck B, Hayflick JS, Marshall AJ. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation. J Immunol 2007 178 : 2328 2335.
64. Fabre S, et al. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol 2005 174 : 4161 4171.
65. Harriague J, Bismuth G. Imaging antigen-induced PI3K activation in T cells. Nat Immunol 2002 3 : 1090 1096.
66. Costello PS, Gallagher M, Cantrell DA. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat Immunol 2002 3 : 1082 1089.
67. Huppa JB, Gleimer M, Sumen C, Davis MM. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat Immunol 2003 4 : 749 755.
68. Okkenhaug K, Ali K, Vanhaesebroeck B. Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends Immunol 2007 28 : 80 87.
69. Burr JS, et al. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol 2001 166 : 5331 5335.
70. Okkenhaug K, Patton DT, Bilancio A, Garcon F, Rowan WC, Vanhaesebroeck B. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 2006 177 : 5122 5128.
71. Okkenhaug K, Vanhaesebroeck B. New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE 2001 2001 : PE1.
72. Sanchez-Lockhart M, et al. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol 2004 173 : 7120 7124.
73. Garcon F, et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 2008 111 : 1464 1471.
74. Fos C, et al. ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse. J Immunol 2008 181 : 1969 1977.
75. Suzuki H, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 1999 283 : 390 392.
76. Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA. Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase. J Immunol 2004 172 : 6615 6625.
77. Shiroki F, et al. The p85alpha regulatory subunit of class IA phosphoinositide 3-kinase regulates beta-selection in thymocyte development. J Immunol 2007 178 : 1349 1356.
78. Swat W, et al. Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood 2006 107 : 2415 2422.
79. Webb LM, Vigorito E, Wymann MP, Hirsch E, Turner M. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005 175 : 2783 2787.
80. Garcon F, Bismuth G, Isnardon D, Olive D, Nunes JA. Tec kinase migrates to the T cell-APC interface independently of its pleckstrin homology domain. J Immunol 2004 173 : 770 775.
81. Schaeffer EM, et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 1999 284 : 638 641.
82. Alcazar I, et al. Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J Exp Med 2007 204 : 2977 2987.
83. Sasaki T, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000 287 : 1040 1046.
84. Ji H, et al. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 2007 110 : 2940 2947.
85. Thomas MS, Mitchell JS, Denucci CC, Martin AL, Shimizu Y. The p110 gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites. J Leukoc Biol 2008 84 : 814 823.
86. Martin AL, Schwartz MD, Jameson SC, Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidylinositol 3-kinase. J Immunol 2008 180 : 2081 2088.
87. Friedman RS, Jacobelli J, Krummel MF. Surface-bound chemokines capture and prime T cells for synapse formation. Nat Immunol 2006 7 : 1101 1108.
88. Molon B, et al. T cell costimulation by chemokine receptors. Nat Immunol 2005 6 : 465 471.
89. Schenk U, et al. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Science signaling 2008 1 : ra6.
90. Strainic MG, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4 + T cells. Immunity 2008 28 : 425 435.
91. Kang H, Schneider H, Rudd CE. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110. J Biol Chem 2002 277 : 912 921.
92. Hartley D, Corvera S. Formation of c-Cbl.phosphatidylinositol 3-kinase complexes on lymphocyte membranes by a p56lck-independent mechanism. J Biol Chem 1996 271 : 21939 21943.
93. Hartley D, Meisner H, Corvera S. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem 1995 270 : 18260 18263.
94. Soltoff SP, Cantley LC. p120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem 1996 271 : 563 567.
95. Dummler B, Hemmings BA. Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 2007 35 : 231 235.
96. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007 129 : 1261 1274.
97. Ohashi PS. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol 2002 2 : 427 438.
98. Fayard E, Gill J, Paolino M, Hynx D, Hollander GA, Hemmings BA. Deletion of PKBalpha/Akt1 affects thymic development. PLoS ONE 2007 2 : e992.
99. Juntilla MM, Wofford JA, Birnbaum MJ, Rathmell JC, Koretzky GA. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc Natl Acad Sci USA 2007 104 : 12105 12110.
100. Donahue AC, Fruman DA. Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur J Immunol 2007 37 : 2923 2936.
101. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell 2007 12 : 487 502.
102. Wlodarski P, et al. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res 2005 65 : 7800 7808.
103. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005 307 : 1098 1101.
104. Sarbassov DD, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006 22 : 159 168.
105. Peng SL. Foxo in the immune system. Oncogene 2008 27 : 2337 2344.
106. Yusuf I, Fruman DA. Regulation of quiescence in lymphocytes. Trends Immunol 2003 24 : 380 386.
107. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA. Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004 104 : 784 787.
108. Chen J, Yusuf I, Andersen HM, Fruman DA. FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes. J Immunol 2006 176 : 2711 2721.
109. Yusuf I, et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol 2008 20 : 671 681.
110. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004 21 : 203 213.
111. Calnan DR, Brunet A. The FoxO code. Oncogene 2008 27 : 2276 2288.
112. Fabre S, et al. FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol 2008 181 : 2980 2989.
113. Doughty CA, et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006 107 : 4458 4465.
114. Frauwirth KA, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002 16 : 769 777.
115. Jacobs SR, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 2008 180 : 4476 4486.
116. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008 7 : 11 20.
117. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005 5 : 844 852.
118. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene 2008 27 : 2320 2336.
119. Tze LE, et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS biol 2005 3 : e82.
120. Verkoczy L, et al. Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol 2007 178 : 6332 6341.
121. Amin RH, Schlissel MS. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 2008 9 : 613 622.
122. Herzog S, et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat Immunol 2008 9 : 623 631.
123. Donahue AC, Hess KL, Ng KL, Fruman DA. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. Int Immunol 2004 16 : 1789 1798.
124. Otipoby KL, et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 2008 105 : 12435 12438.
125. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006 203 : 2551 2562.
126. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008 20 : 149 157.
127. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006 7 : 619.
128. Martelli AM, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Curr Med Chem 2007 14 : 2009 2023.
129. Kharas MG, Fruman DA. ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. Cancer Res 2005 65 : 2047 2053.
130. Kharas MG, et al. Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells. Blood 2004 103 : 4268 4275.
131. Billottet C, et al. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene 2006 25 : 6648 6659.
132. Sujobert P, et al. Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 2005 106 : 1063 1066.
133. Oak JS, et al. Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 2006 103 : 16882 16887.
134. Nashed BF, et al. Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 2007 37 : 416 424.
135. Oak JS, Fruman DA. Role of phosphoinositide 3-kinase signaling in autoimmunity. Autoimmunity 2007 40 : 433 441.
136. Patton DT, et al. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+ CD25+ Foxp3+ regulatory T cells. J Immunol 2006 177 : 6598 6602.
137. Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4 + Foxp3 + cells. J Exp Med 2008 205 : 565 574.
138. Sauer S, et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 2008 105 : 7797 7802.
139. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005 6 : 1142 1151.
140. Crellin NK, Garcia RV, Levings MK. Altered activation of AKT is required for the suppressive function of human CD4+ CD25+ T regulatory cells. Blood 2007 109 : 2014 2022.
141. Oak JS, Matheu MP, Parker I, Cahalan MD, Fruman DA. Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase. Biochem Soc Trans 2007 35 : 1109 1113.
142. Nombela-Arrieta C, et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004 21 : 429 441.
143. Nombela-Arrieta C, et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J Exp Med 2007 204 : 497 510.
144. Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 2004 173 : 2236 2240.
145. Cahalan MD, Parker I. Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs. Annu Rev Immunol 2008 26 : 585 626.
146. Bajenoff M, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006 25 : 989 1001.
147. Asperti-Boursin F, Real E, Bismuth G, Trautmann A, Donnadieu E. CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3-kinase-independent manner. J Exp Med 2007 204 : 1167 1179.
148. Huang JH, et al. Requirements for T lymphocyte migration in explanted lymph nodes. J Immunol 2007 178 : 7747 7755.
149. Hwang IY, Park C, Kehrl JH. Impaired trafficking of Gnai2+/- and Gnai2-/- T lymphocytes: implications for T cell movement within lymph nodes. J Immunol 2007 179 : 439 448.
150. Real E, Faure S, Donnadieu E, Delon J. Cutting edge: atypical PKCs regulate T lymphocyte polarity and scanning behavior. J Immunol 2007 179 : 5649 5652.
151. Worbs T, Mempel TR, Bolter J, von Andrian UH, Forster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007 204 : 489 495.
152. Lammermann T, et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008 453 : 51 55.
153. Woolf E, et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol 2007 8 : 1076 1085.
154. Sinclair LV, et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 2008 9 : 513 521.
155. Carlson CM, et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006 442 : 299 302.
156. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 2008 9 : 292 300.
157. Barbee SD, Alberola-Ila J. Phosphatidylinositol 3-kinase regulates thymic exit. J Immunol 2005 174 : 1230 1238.
158. Jarmin SJ, et al. T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice. J Clin Invest 2008 118 : 1154 1164.
159. Mirenda V, et al. Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 2007 109 : 2968 2977.
160. Garcia-Echeverria C, Sellers WR. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 2008 27 : 5511 5526.
161. Rommel C, Camps M, Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Drug Discov 2007 7 : 191 201.
162. Ruckle T, Schwarz MK, Rommel C. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'? Nat Rev Drug Discov 2006 5 : 903 918.
163. Workman P, Clarke PA, Guillard S, Raynaud FI. Drugging the PI3 kinome. Nat Biotechnol 2006 24 : 794 796.
164. Maira SM, et al. Identification and characterization of NVP-BEZ235, a new orally vailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008 7 : 1851 1863.
165. Ali K, et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004 431 : 1007 1011.
166. Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 2006 20 : 455 465.
167. Lee KS, et al. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol 2006 118 : 403 409.
168. Puri KD, et al. Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 2004 103 : 3448 3456.
169. Randis TM, Puri KD, Zhou H, Diacovo TG. Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol 2008 38 : 1215 1224.
170. Ferreira AM, Isaacs H, Hayflick JS, Rogers KA, Sandig M. The p110delta isoform of PI3K differentially regulates beta1 and beta2 integrin-mediated monocyte adhesion and spreading and modulates diapedesis. Microcirculation 2006 13 : 439 456.
171. Pinho V, et al. Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. J Immunol 2007 179 : 7891 7898.
172. Condliffe AM, et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005 106 : 1432 1440.
173. Doukas J, et al. Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. Proc Natl Acad Sci USA 2006 103 : 19866 19871.
174. Gonzalez-Ruiz D, Gohlke H. Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding. Curr Med Chem 2006 13 : 2607 2625.
175. Walensky LD, et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 2004 305 : 1466 1470.
176. Lin X, Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004 16 : 429 435.
177. Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor kappa B. Immunity 2006 25 : 701 715.
178. Sancak Y, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008 320 : 1496 1501.